These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 20857523)

  • 1. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome.
    Malinen E; Krogius-Kurikka L; Lyra A; Nikkilä J; Jääskeläinen A; Rinttilä T; Vilpponen-Salmela T; von Wright AJ; Palva A
    World J Gastroenterol; 2010 Sep; 16(36):4532-40. PubMed ID: 20857523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
    Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
    World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.
    Malinen E; Rinttilä T; Kajander K; Mättö J; Kassinen A; Krogius L; Saarela M; Korpela R; Palva A
    Am J Gastroenterol; 2005 Feb; 100(2):373-82. PubMed ID: 15667495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes.
    Lyra A; Krogius-Kurikka L; Nikkilä J; Malinen E; Kajander K; Kurikka K; Korpela R; Palva A
    BMC Gastroenterol; 2010 Sep; 10():110. PubMed ID: 20849659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects.
    Kassinen A; Krogius-Kurikka L; Mäkivuokko H; Rinttilä T; Paulin L; Corander J; Malinen E; Apajalahti J; Palva A
    Gastroenterology; 2007 Jul; 133(1):24-33. PubMed ID: 17631127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria.
    Maukonen J; Satokari R; Mättö J; Söderlund H; Mattila-Sandholm T; Saarela M
    J Med Microbiol; 2006 May; 55(Pt 5):625-633. PubMed ID: 16585652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome.
    Tana C; Umesaki Y; Imaoka A; Handa T; Kanazawa M; Fukudo S
    Neurogastroenterol Motil; 2010 May; 22(5):512-9, e114-5. PubMed ID: 19903265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
    Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
    J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.
    Rajilić-Stojanović M; Biagi E; Heilig HG; Kajander K; Kekkonen RA; Tims S; de Vos WM
    Gastroenterology; 2011 Nov; 141(5):1792-801. PubMed ID: 21820992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.
    Krogius-Kurikka L; Lyra A; Malinen E; Aarnikunnas J; Tuimala J; Paulin L; Mäkivuokko H; Kajander K; Palva A
    BMC Gastroenterol; 2009 Dec; 9():95. PubMed ID: 20015409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
    Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
    J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome.
    Rigsbee L; Agans R; Shankar V; Kenche H; Khamis HJ; Michail S; Paliy O
    Am J Gastroenterol; 2012 Nov; 107(11):1740-51. PubMed ID: 22986438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
    Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A
    Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome.
    Sundin J; Aziz I; Nordlander S; Polster A; Hu YOO; Hugerth LW; Pennhag AAL; Engstrand L; Törnblom H; Simrén M; Öhman L
    Sci Rep; 2020 Jan; 10(1):593. PubMed ID: 31953505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.
    Saulnier DM; Riehle K; Mistretta TA; Diaz MA; Mandal D; Raza S; Weidler EM; Qin X; Coarfa C; Milosavljevic A; Petrosino JF; Highlander S; Gibbs R; Lynch SV; Shulman RJ; Versalovic J
    Gastroenterology; 2011 Nov; 141(5):1782-91. PubMed ID: 21741921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial community and metabolomic comparison of irritable bowel syndrome faeces.
    Ponnusamy K; Choi JN; Kim J; Lee SY; Lee CH
    J Med Microbiol; 2011 Jun; 60(Pt 6):817-827. PubMed ID: 21330412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and whole genome sequencing of a Ruminococcus-like bacterium, associated with irritable bowel syndrome.
    Hynönen U; Rasinkangas P; Satokari R; Paulin L; de Vos WM; Pietilä TE; Kant R; Palva A
    Anaerobe; 2016 Jun; 39():60-7. PubMed ID: 26946362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.